2022 Double Diamond Sponsors
Supernus Pharmaceuticals is dedicated to central nervous system diseases, with a passionate focus on Parkinson's disease (PD). We hold a fundamental belief that our science has the potential to help people living with PD. We're committed to people with PD, their care partners, and the HCPs who help manage it. Our currently available treatment options, and ongoing research, reflect our resolve to help the Parkinson's community.
Be icONic with PD
Be icONic with PD is a community that recognizes and celebrates the fact that People with Parkinson's (PwP) are more than PD. The word iconic was chosen to highlight the commitment that thousands of PwP and care partners exercise every day to live a life with passion and purpose. Being iconic means embracing activities big and small -- errands, time with loved ones, staying active and sharing tips and tricks for living with PD. Put PD in its place: last on the list of what defines PwP.
2022 Diamond Sponsors
At Amneal, we are committed to people living with Parkinson's disease. We believe that every dose and every detail makes a difference–and that together, with patients, care partners, healthcare providers, and advocacy, we can achieve so much more.
2022 Platinum Sponsors
Acorda Therapeutics is a biopharmaceutical company that markets two products, including INBRIJA® (levodopa inhalation powder). www.acorda.com and www.inbrija.com
2022 Movement Disorder & Rehabilitation Centers
Unity Walk Partners and Parkinson's Advocacy Groups
SPONSOR AND FOUNDATION NEWS
- Avion Pharmaceuticals Announces the FDA Approval and Availability of DHIVY™
- LSVT Announces Aware in Care Information Session: Helping individuals with Parkinson’s disease stay safe while in the hospital
- Amneal Announces Positive Topline Results from Pivotal Phase 3 RISE-PD Clinical Trial of IPX-203 in Patients with Parkinson’s Disease Who Experience Motor Fluctuations
- Supernus bolsters Parkinson's portfolio with $400 million deal for Adamas Pharma